Pre-print study with references to Yang & Patterso
Post# of 148165
The CCR5-delta32 variant might explain part of the association between COVID-19 and the chemokine-receptor gene cluster
"These and other studies pointed to CCR5 as a potential target for COVID-19 treatment. The genetic analysis of CCR5-variants, such as Δ32, might help to identify patients with a higher susceptibility to severe COVID-19."
https://www.medrxiv.org/content/10.1101/2020....659v1.full